statement
CJ제일제당's 3Q results met market expectations and balanced growth across 식품 및 바이오 사업부 was confirmed.
A statement by report author. Statements are as reported by the cited publishers — not verified by DecisionGateway.
CJ제일제당은 3분기 실적이 시장 기대치에 부합한 가운데 식품 및 바이오 사업부의 고른 성장이 확인되었습니다.
Related claims
CJ제일제당 recorded 3Q26 consolidated revenue of 7조 3,952억원 and operating profit of 3,090억원, in line with market expectations.report author · statementDespite somewhat disappointing company-wide third-quarter results, KT is continuing to improve its fundamentals centered on the recovering core business and the fast-growing AX segment.report · statement3Q26 CJ대한통운 revenue rose 10% YoY to 3조 3,581억원 and operating profit fell 25% to 1,105억원 (3.3% margin), in line with consensus.하나증권 운송/모빌리티 Analyst 안도현 · statementKT recorded third-quarter consolidated revenue of 6조9,775억원 and operating profit of 5,053억원, with a turnaround in its core business underway.report · statementKT's third-quarter results were weak due to reduced device margins and increased overall business expenses, but the related negatives are already reflected in the share price; at the current 50,000 won level, active buying is warranted.analyst report · statementKrafton's Q3 results missed consensus, with revenue of 971.4 billion KRW and operating profit of 225.0 billion KRW.하나증권 · statement